New drug shows promise for fatty liver – but Long-Term control needed
NCT ID NCT06410924
First seen Apr 23, 2026 · Last updated May 13, 2026 · Updated 4 times
Summary
This study tested a new drug called DD01 in 67 overweight or obese adults with a type of fatty liver disease (MASLD/MASH). The goal was to see if DD01 could safely reduce liver fat over 48 weeks. Participants were randomly assigned to receive DD01 or a placebo, and researchers measured liver fat using MRI scans. The results will help determine if DD01 can help control this liver condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAFLD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Summit Research Site
Maitland, Florida, 92751, United States
-
Summit Research Site
Monroe, Louisiana, 71201, United States
-
Summit Research Site
West Monroe, Louisiana, 71291, United States
-
Summit Research Site
Kansas City, Missouri, 64131, United States
-
Summit Research Site
Austin, Texas, 78757, United States
-
Summit Research Site
Bellaire, Texas, 77401, United States
-
Summit Research Site
Brownsville, Texas, 78520, United States
-
Summit Research Site
Corpus Christi, Texas, 78404, United States
-
Summit Research Site
Edinburg, Texas, 78539, United States
-
Summit Research Site
Georgetown, Texas, 78626, United States
-
Summit Research Site
San Antonio, Texas, 78222, United States
-
Summit Research Site
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.